Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial. - Lassman AB; Polley MC; Iwamoto FM; Sloan AE; Wang TJC; Aldape KD; Wefel JS; Gondi V; Gutierrez AN; Manasawala MH; Gilbert MR; Sulman EP; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)